Eiger BioPharmaceuticals, Inc.
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA

Last updated:

Abstract:

Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.

Status:
Application
Type:

Utility

Filling date:

18 Feb 2021

Issue date:

29 Jul 2021